Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Chinese Pharma Looks To Out-Licensing As Domestic Downturn Bites
Nov 22 2022
•
By
Dexter Jie Yan
struggling Chinese drug makers scramble for licensing deals amid economic downturn • Source: Shutterstock
Keep up with the top pharma business news of the week. On the go.
Scrip brings you a weekly bulletin of top picks.
More from China
More from Focus On Asia